Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
Biopharmaceutical and Vaccines market report explains the definition, types, applications, major countries, and major players of the Biopharmaceutical and Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Boehringer Ingelheim
Roche
Sanofi
Biogen Idec
Abbott
GlaxoSmithKline
Alexion Pharmaceuticals
Pfizer
Johnson and Johnson
Rentschler
Merck
Lonza
Regeneron Pharmaceuticals
Novartis
By Type:
Biopharmaceutical
Vaccine Production
By End-User:
Pharmaceuticals Industry
Clinical Diagnosis
Scientific Research
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Biopharmaceutical and Vaccines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Biopharmaceutical and Vaccines Outlook to 2028- Original Forecasts
-
2.2 Biopharmaceutical and Vaccines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Biopharmaceutical and Vaccines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Biopharmaceutical and Vaccines Market- Recent Developments
-
6.1 Biopharmaceutical and Vaccines Market News and Developments
-
6.2 Biopharmaceutical and Vaccines Market Deals Landscape
7 Biopharmaceutical and Vaccines Raw Materials and Cost Structure Analysis
-
7.1 Biopharmaceutical and Vaccines Key Raw Materials
-
7.2 Biopharmaceutical and Vaccines Price Trend of Key Raw Materials
-
7.3 Biopharmaceutical and Vaccines Key Suppliers of Raw Materials
-
7.4 Biopharmaceutical and Vaccines Market Concentration Rate of Raw Materials
-
7.5 Biopharmaceutical and Vaccines Cost Structure Analysis
-
7.5.1 Biopharmaceutical and Vaccines Raw Materials Analysis
-
7.5.2 Biopharmaceutical and Vaccines Labor Cost Analysis
-
7.5.3 Biopharmaceutical and Vaccines Manufacturing Expenses Analysis
8 Global Biopharmaceutical and Vaccines Import and Export Analysis (Top 10 Countries)
-
8.1 Global Biopharmaceutical and Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Biopharmaceutical and Vaccines Export by Region (Top 10 Countries) (2017-2028)
9 Global Biopharmaceutical and Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Biopharmaceutical and Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Vaccine Production Consumption and Growth Rate (2017-2022)
-
9.2 Global Biopharmaceutical and Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pharmaceuticals Industry Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinical Diagnosis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Scientific Research Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Biopharmaceutical and Vaccines Market Analysis and Outlook till 2022
-
10.1 Global Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.2.2 Canada Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.2.3 Mexico Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.2 UK Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.3 Spain Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.4 Belgium Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.5 France Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.6 Italy Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.7 Denmark Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.8 Finland Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.9 Norway Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.10 Sweden Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.11 Poland Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.12 Russia Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.3.13 Turkey Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.2 Japan Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.3 India Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.4 South Korea Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.5 Pakistan Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.6 Bangladesh Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.7 Indonesia Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.8 Thailand Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.9 Singapore Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.10 Malaysia Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.11 Philippines Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.4.12 Vietnam Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.5.2 Colombia Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.5.3 Chile Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.5.4 Argentina Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.5.5 Venezuela Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.5.6 Peru Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.5.7 Puerto Rico Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.5.8 Ecuador Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.6.2 Kuwait Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.6.3 Oman Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.6.4 Qatar Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.6.5 Saudi Arabia Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.6.6 United Arab Emirates Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.7.2 South Africa Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.7.3 Egypt Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.7.4 Algeria Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Biopharmaceutical and Vaccines Consumption (2017-2022)
-
10.8.2 New Zealand Biopharmaceutical and Vaccines Consumption (2017-2022)
11 Global Biopharmaceutical and Vaccines Competitive Analysis
-
11.1 Boehringer Ingelheim
-
11.1.1 Boehringer Ingelheim Company Details
-
11.1.2 Boehringer Ingelheim Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.1.4 Boehringer Ingelheim Biopharmaceutical and Vaccines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Roche
-
11.2.1 Roche Company Details
-
11.2.2 Roche Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Roche Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.2.4 Roche Biopharmaceutical and Vaccines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Sanofi
-
11.3.1 Sanofi Company Details
-
11.3.2 Sanofi Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Sanofi Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.3.4 Sanofi Biopharmaceutical and Vaccines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Biogen Idec
-
11.4.1 Biogen Idec Company Details
-
11.4.2 Biogen Idec Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Biogen Idec Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.4.4 Biogen Idec Biopharmaceutical and Vaccines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Abbott
-
11.5.1 Abbott Company Details
-
11.5.2 Abbott Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Abbott Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.5.4 Abbott Biopharmaceutical and Vaccines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 GlaxoSmithKline
-
11.6.1 GlaxoSmithKline Company Details
-
11.6.2 GlaxoSmithKline Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 GlaxoSmithKline Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.6.4 GlaxoSmithKline Biopharmaceutical and Vaccines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Alexion Pharmaceuticals
-
11.7.1 Alexion Pharmaceuticals Company Details
-
11.7.2 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.7.4 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Pfizer
-
11.8.1 Pfizer Company Details
-
11.8.2 Pfizer Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Pfizer Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.8.4 Pfizer Biopharmaceutical and Vaccines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Johnson and Johnson
-
11.9.1 Johnson and Johnson Company Details
-
11.9.2 Johnson and Johnson Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.9.4 Johnson and Johnson Biopharmaceutical and Vaccines Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Rentschler
-
11.10.1 Rentschler Company Details
-
11.10.2 Rentschler Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Rentschler Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.10.4 Rentschler Biopharmaceutical and Vaccines Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Merck
-
11.11.1 Merck Company Details
-
11.11.2 Merck Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Merck Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.11.4 Merck Biopharmaceutical and Vaccines Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Lonza
-
11.12.1 Lonza Company Details
-
11.12.2 Lonza Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Lonza Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.12.4 Lonza Biopharmaceutical and Vaccines Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Regeneron Pharmaceuticals
-
11.13.1 Regeneron Pharmaceuticals Company Details
-
11.13.2 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.13.4 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Novartis
-
11.14.1 Novartis Company Details
-
11.14.2 Novartis Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Novartis Biopharmaceutical and Vaccines Main Business and Markets Served
-
11.14.4 Novartis Biopharmaceutical and Vaccines Product Portfolio
-
11.14.5 Recent Research and Development Strategies
12 Global Biopharmaceutical and Vaccines Market Outlook by Types and Applications to 2028
-
12.1 Global Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Pharmaceuticals Industry Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinical Diagnosis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Biopharmaceutical and Vaccines Market Analysis and Outlook to 2028
-
13.1 Global Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.2.2 Canada Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.2.3 Mexico Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.2 UK Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.3 Spain Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.4 Belgium Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.5 France Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.6 Italy Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.7 Denmark Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.8 Finland Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.9 Norway Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.10 Sweden Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.11 Poland Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.12 Russia Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.3.13 Turkey Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.2 Japan Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.3 India Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.4 South Korea Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.8 Thailand Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.9 Singapore Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.11 Philippines Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.5.2 Colombia Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.5.3 Chile Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.5.4 Argentina Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.5.6 Peru Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.6.3 Oman Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.6.4 Qatar Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.7.2 South Africa Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.7.3 Egypt Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.7.4 Algeria Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Biopharmaceutical and Vaccines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Biopharmaceutical and Vaccines
-
Figure of Biopharmaceutical and Vaccines Picture
-
Table Global Biopharmaceutical and Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Biopharmaceutical and Vaccines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Biopharmaceutical Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccine Production Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceuticals Industry Consumption and Growth Rate (2017-2022)
-
Figure Global Clinical Diagnosis Consumption and Growth Rate (2017-2022)
-
Figure Global Scientific Research Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Biopharmaceutical and Vaccines Consumption by Country (2017-2022)
-
Table North America Biopharmaceutical and Vaccines Consumption by Country (2017-2022)
-
Figure United States Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Canada Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Mexico Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Biopharmaceutical and Vaccines Consumption by Country (2017-2022)
-
Figure Germany Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure UK Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Spain Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Belgium Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure France Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Italy Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Denmark Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Finland Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Norway Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Sweden Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Poland Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Russia Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Turkey Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Table APAC Biopharmaceutical and Vaccines Consumption by Country (2017-2022)
-
Figure China Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Thailand Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Singapore Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Philippines Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Table South America Biopharmaceutical and Vaccines Consumption by Country (2017-2022)
-
Figure Brazil Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Colombia Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Chile Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Argentina Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Peru Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Table GCC Biopharmaceutical and Vaccines Consumption by Country (2017-2022)
-
Figure Bahrain Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Oman Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Qatar Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Africa Biopharmaceutical and Vaccines Consumption by Country (2017-2022)
-
Figure Nigeria Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Africa Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Egypt Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Algeria Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Oceania Biopharmaceutical and Vaccines Consumption by Country (2017-2022)
-
Figure Australia Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Biopharmaceutical and Vaccines Consumption and Growth Rate (2017-2022)
-
Table Boehringer Ingelheim Company Details
-
Table Boehringer Ingelheim Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Boehringer Ingelheim Biopharmaceutical and Vaccines Product Portfolio
-
Table Roche Company Details
-
Table Roche Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Roche Biopharmaceutical and Vaccines Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Sanofi Biopharmaceutical and Vaccines Product Portfolio
-
Table Biogen Idec Company Details
-
Table Biogen Idec Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Biogen Idec Biopharmaceutical and Vaccines Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Abbott Biopharmaceutical and Vaccines Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table GlaxoSmithKline Biopharmaceutical and Vaccines Product Portfolio
-
Table Alexion Pharmaceuticals Company Details
-
Table Alexion Pharmaceuticals Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alexion Pharmaceuticals Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Alexion Pharmaceuticals Biopharmaceutical and Vaccines Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Pfizer Biopharmaceutical and Vaccines Product Portfolio
-
Table Johnson and Johnson Company Details
-
Table Johnson and Johnson Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Johnson and Johnson Biopharmaceutical and Vaccines Product Portfolio
-
Table Rentschler Company Details
-
Table Rentschler Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rentschler Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Rentschler Biopharmaceutical and Vaccines Product Portfolio
-
Table Merck Company Details
-
Table Merck Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Merck Biopharmaceutical and Vaccines Product Portfolio
-
Table Lonza Company Details
-
Table Lonza Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lonza Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Lonza Biopharmaceutical and Vaccines Product Portfolio
-
Table Regeneron Pharmaceuticals Company Details
-
Table Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Biopharmaceutical and Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Biopharmaceutical and Vaccines Main Business and Markets Served
-
Table Novartis Biopharmaceutical and Vaccines Product Portfolio
-
Figure Global Biopharmaceutical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccine Production Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceuticals Industry Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinical Diagnosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Scientific Research Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biopharmaceutical and Vaccines Consumption Forecast by Country (2022-2028)
-
Table North America Biopharmaceutical and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biopharmaceutical and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Germany Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Biopharmaceutical and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure China Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Biopharmaceutical and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Brazil Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Biopharmaceutical and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Biopharmaceutical and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Biopharmaceutical and Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Australia Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Biopharmaceutical and Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
